|
1
|
Melendez-Ramirez LY, Richards RJ and
Cefalu WT: Complications of type 1 diabetes. Endocrinol Metab Clin
North Am. 39:625–640. 2010. View Article : Google Scholar
|
|
2
|
Gheissari A, Javanmard SH, Shirzadi R,
Amini M and Khalili N: The effects of blocking Angiotensin
receptors on early stages of diabetic nephropathy. Int J Prev Med.
3:477–482. 2012.PubMed/NCBI
|
|
3
|
Hirst JA, Taylor KS, Stevens RJ, et al:
The impact of renin-angiotensin-aldosterone system inhibitors on
Type 1 and Type 2 diabetic patients with and without early diabetic
nephropathy. Kidney Int. 81:674–683. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vejakama P, Thakkinstian A, Lertrattananon
D, Ingsathit A, Ngarmukos C and Attia J: Reno-protective effects of
renin-angiotensin system blockade in type 2 diabetic patients: a
systematic review and network meta-analysis. Diabetologia.
55:566–578. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tonna S, El-Osta A, Cooper ME and Tikellis
C: Metabolic memory and diabetic nephropathy: potential role for
epigenetic mechanisms. Nat Rev Nephrol. 6:332–341. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reddy MA and Natarajan R: Epigenetics in
diabetic kidney disease. J Am Soc Nephrol. 22:2182–2185. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maier S and Olek A: Diabetes: a candidate
disease for efficient DNA methylation profiling. J Nutr. 132(Suppl
8): 2440S–2443S. 2002.PubMed/NCBI
|
|
8
|
Bell CG, Teschendorff AE, Rakyan VK,
Maxwell AP, Beck S and Savage DA: Genome-wide DNA methylation
analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC
Med Genomics. 3:332010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guha M, Xu ZG, Tung D, Lanting L and
Natarajan R: Specific down-regulation of connective tissue growth
factor attenuates progression of nephropathy in mouse models of
type 1 and type 2 diabetes. FASEB J. 21:3355–3368. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nguyen TQ, Tarnow L, Jorsal A, et al:
Plasma connective tissue growth factor is an independent predictor
of end-stage renal disease and mortality in type 1 diabetic
nephropathy. Diabetes Care. 31:1177–1182. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kikuchi R, Tsuda H, Kanai Y, et al:
Promoter hypermethylation contributes to frequent inactivation of a
putative conditional tumor suppressor gene connective tissue growth
factor in ovarian cancer. Cancer Res. 67:7095–7105. 2007.
View Article : Google Scholar
|
|
12
|
Chiba T, Yokosuka O, Fukai K, et al:
Identification and investigation of methylated genes in hepatoma.
Eur J Cancer. 41:1185–1194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yi B, Zhang H, Zhou H, Cai X, Sun J and
Liu Y: High glucose induce the demethylation of CTGF promoter and
gene expression. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 27:747–750.
2011.(In Chinese).
|
|
14
|
Bennett PH: Impact of the new WHO
classification and diagnostic criteria. Diabetes Obes Metab. (Suppl
2): S1–S6. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
National Kidney Foundation. KDOQI clinical
practice guideline for diabetes and CKD: 2012 update. Am J Kidney
Dis. 60:850–886. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nichols GA, Vupputuri S and Lau H: Medical
care costs associated with progression of diabetic nephropathy.
Diabetes Care. 34:2374–2378. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bechtel W, McGoohan S, Zeisberg EM, et al:
Methylation determines fibroblast activation and fibrogenesis in
the kidney. Nat Med. 16:544–550. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dwivedi RS, Herman JG, McCaffrey TA and
Raj DS: Beyond genetics: epigenetic code in chronic kidney disease.
Kidney Int. 79:23–32. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Laborie LB, Mackay DJ, Temple IK, Molven
A, Søvik O and Njølstad PR: DNA hypomethylation, transient neonatal
diabetes, and prune belly sequence in one of two identical twins.
Eur J Pediatr. 169:207–213. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Varrault A, Bilanges B, Mackay DJ, et al:
Characterization of the methylation-sensitive promoter of the
imprinted ZAC gene supports its role in transient neonatal diabetes
mellitus. J Biol Chem. 276:18653–18656. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nanayakkara PW, Kiefte-de Jong JC,
Stehouwer CD, et al: Association between global leukocyte DNA
methylation, renal function, carotid intima-media thickness and
plasma homocysteine in patients with stage 2–4 chronic kidney
disease. Nephrol Dial Transplant. 23:2586–2592. 2008.PubMed/NCBI
|
|
22
|
Kuroda A, Rauch TA, Todorov I, et al:
Insulin gene expression is regulated by DNA methylation. PLoS One.
4:e69532009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang BT, Dayeh TA, Kirkpatrick CL, et al:
Insulin promoter DNA methylation correlates negatively with insulin
gene expression and positively with HbA(1c) levels in human
pancreatic islets. Diabetologia. 54:360–367. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Du J, Wang L, Liu X, et al: Janus kinase
2/signal transducers and activators of transcription signal
inhibition regulates protective effects of probucol on mesangial
cells treated with high glucose. Biol Pharm Bull. 33:768–772. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li X, Liu W, Wang Q, et al: Emodin
suppresses cell proliferation and fibronectin expression via
p38MAPK pathway in rat mesangial cells cultured under high glucose.
Mol Cell Endocrinol. 307:157–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
El Mesallamy HO, Ahmed HH, Bassyouni AA
and Ahmed AS: Clinical significance of inflammatory and fibrogenic
cytokines in diabetic nephropathy. Clin Biochem. 45:646–650.
2012.PubMed/NCBI
|
|
27
|
Tam FW, Riser BL, Meeran K, Rambow J,
Pusey CD and Frankel AH: Urinary monocyte chemoattractant protein-1
(MCP-1) and connective tissue growth factor (CCN2) as prognostic
markers for progression of diabetic nephropathy. Cytokine.
47:37–42. 2009. View Article : Google Scholar : PubMed/NCBI
|
